| Name | Title | Contact Details |
|---|
Founded in Los Angeles in 2007, Cinesamples has grown to become an industry leader in the development of top virtual instruments and sample libraries. We are passionate about the sampling process, and you can hear our products in many films, tv shows, and video games.
Atleos (NYSE: NATL) is a leader in expanding self-service financial access, with industry-leading ATM expertise and experience, unrivalled operational scale including the largest independently-owned ATM network, always-on global services and constant innovation. Atleos improves operational efficiency for financial institutions, drives footfall for retailers and enables digital-first financial self-service experiences for consumers. Atleos is headquartered in Atlanta, Georgia, with approximately 20,000 employees globally.
Commencement Bank, headquartered in Tacoma, WA, was formed in 2006. We provide traditional, reliable, and sustainable banking in Pierce County, South King County, Thurston County and the surrounding areas. Our team of experienced banking experts focuses on personal attention, flexible service, and building strong relationships with customers. As a local bank, Commencement Bank is deeply committed to the community.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Mitsubishi Polyester Film is a leading supplier of polyester (PET) film, part of Mitsubishi Chemical America, Inc. The company operates manufacturing sites in the USA, Europe, Japan, Indonesia, and China, with a total global capacity of 250,000 tons. It specializes in biaxially oriented polyester (boPET) films, offering a range of thicknesses and polymer types for various applications. Key brands include Hostaphan® and Diafoil®. The company emphasizes vertical integration, with on-site PET resin manufacturing and over 50 coating types. It also focuses on sustainability through initiatives like the REPROCESS™ recycling program, which incorporates post-industrial recycled content. Mitsubishi Polyester Film provides customized solutions through its global R&D efforts, addressing product design, manufacturing, logistics, and process challenges.